特雷维治疗 TRVI
$14.33 +$1.52 (+11.87%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $14.90 +3.98%
开盘$13.04
昨收$12.81
当日区间$13.00 – $14.36
成交量2.55M
市值$2.04B
市盈率（TTM）–
股息率–
财报
财报日平均波动±2.9%近16次财报
收涨次数6 / 1638% 的概率
最佳反应+4.5%
最差反应-9.0%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 6 Aug 2026 | After Market | ±13.3% | +0.05% | 符合区间 |
| 2026/Q1 | 5 May 2026 | After Market | ±8.3% | -2.73% | 符合区间 |
| 2025/Q4 | 17 Mar 2026 | After Market | ±13.9% | -4.47% | 符合区间 |
| 2025/Q3 | 13 Nov 2025 | After Market | ±11.9% | -0.79% | 符合区间 |
| 2025/Q2 | 7 Aug 2025 | After Market | ±13.0% | +1.64% | 符合区间 |
| 2025/Q1 | 8 May 2025 | After Market | ±14.4% | +0.00% | 符合区间 |
| 2024/Q4 | 18 Mar 2025 | After Market | ±15.3% | +3.81% | 符合区间 |
| 2024/Q3 | 6 Nov 2024 | After Market | – | -6.45% | – |
| 2024/Q2 | 8 Aug 2024 | After Market | – | +2.14% | – |
| 2024/Q1 | 7 May 2024 | After Market | ±37.9% | -8.97% | 符合区间 |
| 2023/Q4 | 20 Mar 2024 | After Market | – | +4.52% | – |
| 2023/Q3 | 9 Nov 2023 | After Market | – | -3.32% | – |
| 2023/Q2 | 10 Aug 2023 | None | ±31.8% | -0.42% | 符合区间 |
| 2023/Q1 | 11 May 2023 | None | ±30.7% | -5.67% | 符合区间 |
| 2022/Q4 | 16 Mar 2023 | After Market | ±99.4% | -1.11% | 符合区间 |
| 2022/Q3 | 10 Nov 2022 | After Market | ±39.9% | +1.04% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$20.51M-49.5% YoY
净利润-$17.80M-44.7% YoY
摊薄每股收益-$0.11-22.2% YoY
自由现金流-$17.55M-73.8% YoY
经营现金流-$17.43M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
净资产收益率-19.7%
资产收益率-19.0%
投入资本回报率-22.8%
流动比率37.28
负债/资产比率2.7%
现金及投资$318.87M
总负债$276,000.00
净现金（净负债）$318.59M
暂无评论——快来第一个聊聊 TRVI。
登录后参与讨论。